| abstract |
A method of treating an eye disorder or retinal disorder is provided. A pharmaceutical composition containing an α 2 adrenergic receptor agonist is administered intravitreally. α 2 adrenergic receptor agonists, the formula I: [Wherein the 2-imidazolinylamino group is at the 5/6 position of the quinoxaline ring skeleton. x, y and z are in the 5th to 8th positions and are selected from hydrogen and the like. R is in the 2/3 position of the quinoxaline ring skeleton, such as hydrogen. Or a pharmaceutically acceptable salt thereof or a mixture thereof. [Selection] Figure 1 |